{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:29:11Z","timestamp":1786728551410,"version":"build-2736575974"},"reference-count":47,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Orthop Surg (Hong Kong)"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pathological fractures (PFs) are clinically important skeletal-related events in patients with bone metastases from solid tumors and may negatively affect survival. This meta-analysis aimed to quantify the association between PFs and overall survival (OS) in patients with metastatic solid cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis was conducted in accordance with PRISMA 2020 using a PICOS-defined protocol. PubMed\/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library were searched from inception to 2025 without language restrictions. Eligible studies included adults with metastatic solid tumors, compared patients with and without PFs, and reported OS using hazard ratios (HRs). Tumor types were pooled a priori because the included studies evaluated the same exposure-comparator-outcome framework across metastatic solid tumors. Random-effects models were used, and heterogeneity was explored through moderator analyses and meta-regression. Two reviewers independently screened records, extracted data, and assessed risk of bias using MINORS for observational studies and the Cochrane tool for randomized trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 198 records, four studies comprising seven cohorts and 3,607 participants met the inclusion criteria. Random-effects pooling showed that PFs were significantly associated with poorer OS compared with no PFs (pooled HR 1.40, 95% CI 1.08\u20131.81; p = 0.010). However, heterogeneity was substantial (I\n                      <jats:sup>2<\/jats:sup>\n                      = 92.6%), indicating that the pooled estimate should be interpreted cautiously. Meta-regression suggested a positive association between publication year and effect size (\u03b2 = 0.041; p = 0.041), whereas primary cancer subgrouping was not a significant moderator. Funnel-plot asymmetry and Egger\u2019s test suggested possible small-study effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PFs appear to be associated with worse OS in patients with metastatic solid tumors, highlighting the importance of fracture prevention, early identification of impending fractures, and multidisciplinary care. Nevertheless, the small evidence base, substantial heterogeneity, and possible publication bias warrant cautious interpretation. Prospective studies with standardized PF definitions and adjusted survival analyses are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10225536261475961","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:45:38Z","timestamp":1786560338000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathological fractures as a prognostic factor for survival in metastatic solid cancers: A meta-analysis"],"prefix":"10.1177","volume":"34","author":[{"given":"Ahmed","family":"Elkohail","sequence":"first","affiliation":[{"name":"Princess Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9999-9728","authenticated-orcid":false,"given":"Ali","family":"Soffar","sequence":"additional","affiliation":[{"name":"Princess Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Khalifa","sequence":"additional","affiliation":[{"name":"Frimley Health NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Omar","sequence":"additional","affiliation":[{"name":"Great Western Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Anber","sequence":"additional","affiliation":[{"name":"Wye Valley NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashis Kumar","family":"Paul","sequence":"additional","affiliation":[{"name":"Princess Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Radu","sequence":"additional","affiliation":[{"name":"Princess Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqil Ahamed Mohideen","family":"Ahamed Sha","sequence":"additional","affiliation":[{"name":"Princess Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elsaket","sequence":"additional","affiliation":[{"name":"Frimley Health NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Abdulaziz","sequence":"additional","affiliation":[{"name":"Frimley Health NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Teama","sequence":"additional","affiliation":[{"name":"Princess Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6297-1707","authenticated-orcid":false,"given":"Ehab","family":"Sharyan","sequence":"additional","affiliation":[{"name":"Sana\u2019a University Faculty of Medicine and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Terra","sequence":"additional","affiliation":[{"name":"Mansoura University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"e0234927","DOI":"10.1371\/journal.pone.0234927","article-title":"Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study","volume":"15","author":"Hong S","year":"2020","unstructured":"Hong S, Youk T, Lee SJ, et al. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study. PLoS One [Internet] 2020; 15: e0234927. https:\/\/doi.org\/10.1371\/journal.pone.0234927","journal-title":"PLoS One [Internet]"},{"key":"e_1_3_4_3_2","unstructured":"Skeletal Complications of Malignancy. [cited 2025 Oct 4]; Available."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.567844"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031252"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13170"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200118120-00002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040893"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2437-3"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0418-0"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0327"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2011.7"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.19.1458"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh141"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61226-9"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2012.42"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.07.062"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32805b72a0"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601158"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32825a6adc"},{"key":"e_1_3_4_21_2","first-page":"24","article-title":"Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer","volume":"27","author":"Fizazi K","year":"2009","unstructured":"Fizazi K, Beuzeboc P, Lumbroso J, et al. Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer. J Clin Oncol 2009; 27: 24\u201335. https:\/\/doi.org\/10.1200\/JCO.2008.18.9811","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.034"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23775"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009327"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-014-9686-x"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3055"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/17453679508995508"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3431-8"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-025-05852-6"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.08.022"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.e17007"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.12115"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1351-x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.21.00711"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060156"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2018.09.044"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt482"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.07.004"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0203-x"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi122"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-004-0625-0"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.25890"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70147-X"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22991"},{"key":"e_1_3_4_45_2","first-page":"302","article-title":"Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome","volume":"52","author":"Ristevski B","year":"2009","unstructured":"Ristevski B, Jenkinson RJ, Stephen DJG, et al. Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome. Canadian Journal of Surgery [Internet] 2009; 52: 302\u2013308. Available from.","journal-title":"Canadian Journal of Surgery [Internet]"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2000.0210"},{"key":"e_1_3_4_47_2","volume-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States","author":"Hernandez RK","year":"2018","unstructured":"Hernandez RK, Wade SW, Reich A, et al. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 2018. [cited 2025 Oct 4];18. Available from. https:\/\/pubmed.ncbi.nlm.nih.gov\/29306325\/"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016022"}],"container-title":["Journal of Orthopaedic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10225536261475961","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10225536261475961","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10225536261475961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:28:33Z","timestamp":1786724913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10225536261475961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/10225536261475961"],"URL":"https:\/\/doi.org\/10.1177\/10225536261475961","relation":{},"ISSN":["1022-5536","2309-4990"],"issn-type":[{"value":"1022-5536","type":"print"},{"value":"2309-4990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"10225536261475961"}}